RS60294B1 - Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti - Google Patents

Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti

Info

Publication number
RS60294B1
RS60294B1 RS20200340A RSP20200340A RS60294B1 RS 60294 B1 RS60294 B1 RS 60294B1 RS 20200340 A RS20200340 A RS 20200340A RS P20200340 A RSP20200340 A RS P20200340A RS 60294 B1 RS60294 B1 RS 60294B1
Authority
RS
Serbia
Prior art keywords
delivery
absorbing materials
fluid absorbing
digestible capsules
digestible
Prior art date
Application number
RS20200340A
Other languages
English (en)
Inventor
Danielle Berger
Original Assignee
Hb Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hb Biotechnologies Corp filed Critical Hb Biotechnologies Corp
Publication of RS60294B1 publication Critical patent/RS60294B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738Cross-linked polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RS20200340A 2011-08-01 2012-08-01 Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti RS60294B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161513923P 2011-08-01 2011-08-01
US201161523787P 2011-08-15 2011-08-15
EP12819632.6A EP2739270B1 (en) 2011-08-01 2012-08-01 Non-digestible capsules for the delivery of fluid absorbing materials
PCT/US2012/049209 WO2013019891A1 (en) 2011-08-01 2012-08-01 Non-digestible capsules for the delivery of fluid absorbing materials

Publications (1)

Publication Number Publication Date
RS60294B1 true RS60294B1 (sr) 2020-07-31

Family

ID=47629668

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20200340A RS60294B1 (sr) 2011-08-01 2012-08-01 Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti

Country Status (15)

Country Link
US (2) US20150216808A1 (sr)
EP (1) EP2739270B1 (sr)
JP (2) JP2014521689A (sr)
CA (1) CA2842802C (sr)
CY (1) CY1123430T1 (sr)
DK (1) DK2739270T3 (sr)
ES (1) ES2782523T3 (sr)
HR (1) HRP20200463T1 (sr)
HU (1) HUE049186T2 (sr)
LT (1) LT2739270T (sr)
PL (1) PL2739270T3 (sr)
PT (1) PT2739270T (sr)
RS (1) RS60294B1 (sr)
SI (1) SI2739270T1 (sr)
WO (1) WO2013019891A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484579B2 (en) * 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (sr) 1958-03-13 1959-11-10
US3042667A (en) 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
SE319903B (sr) 1964-01-31 1970-01-26 Pharmacia Ab
US3300474A (en) 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
US3518340A (en) 1968-04-15 1970-06-30 Dow Corning Method of forming silicone rubber drug carriers
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4663148A (en) * 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising telescopically engaging members
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
AU629915B2 (en) * 1989-02-16 1992-10-15 British Technology Group Limited Dispensing device
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
JP3238350B2 (ja) 1997-05-27 2001-12-10 三粧化研株式会社 可食性パール状カプセルおよびその製造法
WO2002040039A2 (en) * 2000-11-20 2002-05-23 Dow Global Technologies Inc. In vivo use of water absorbent polymers
WO2002062356A2 (en) * 2001-02-06 2002-08-15 Ash Medical Systems, Inc. Monovalent-selective cation exchangers as oral sorbent therapy
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
MXPA05002728A (es) * 2002-09-13 2005-07-25 Cydex Inc Capsulas que contienen composiciones de relleno acuoso estabilizadas con ciclodextrina derivada.
DE50305197D1 (de) * 2003-12-04 2006-11-09 Cognis France Sas Zubereitung für die orale und/oder topische Anwendung (I)
US20070141137A1 (en) 2004-03-04 2007-06-21 Naoki Nagahara Stable capsule preparation
US9233075B2 (en) * 2005-08-09 2016-01-12 Metacure Limited Satiety
JP5372525B2 (ja) 2006-03-03 2013-12-18 エフ エム シー コーポレーション カプセルの製造方法および該製造方法により製造されるカプセル
CA2647487C (en) * 2006-03-29 2014-10-21 Electronic Dietary Foods Inc. Ingestible implement for weight control
US20080268045A1 (en) * 2006-11-09 2008-10-30 Proprius Pharmaceuticals, Inc. Sustained release methotrexate formulations and methods of use thereof
GB0625180D0 (en) * 2006-12-15 2007-01-24 Mw Encap Ltd Improved hard shell capsules
CA2697803A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
WO2009049105A2 (en) * 2007-10-09 2009-04-16 Gelesis, Inc. Methods for inducing satiation
WO2010065784A2 (en) * 2008-12-03 2010-06-10 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
US8101203B2 (en) * 2010-01-14 2012-01-24 Karl Wei Cao Hard capsule composition and method of use

Also Published As

Publication number Publication date
DK2739270T3 (da) 2020-04-06
ES2782523T3 (es) 2020-09-15
US20210330595A1 (en) 2021-10-28
EP2739270B1 (en) 2020-01-01
HUE049186T2 (hu) 2020-09-28
CA2842802C (en) 2020-03-10
JP2017081973A (ja) 2017-05-18
WO2013019891A1 (en) 2013-02-07
JP6446071B2 (ja) 2018-12-26
PT2739270T (pt) 2020-04-02
LT2739270T (lt) 2020-07-10
JP2014521689A (ja) 2014-08-28
PL2739270T3 (pl) 2020-10-05
US20150216808A1 (en) 2015-08-06
EP2739270A4 (en) 2015-01-14
SI2739270T1 (sl) 2020-10-30
CY1123430T1 (el) 2021-12-31
EP2739270A1 (en) 2014-06-11
CA2842802A1 (en) 2013-02-07
HRP20200463T1 (hr) 2020-06-26

Similar Documents

Publication Publication Date Title
LT2758965T (lt) Dviejų skysčių reaktorius
PL2776416T3 (pl) Związki farmaceutyczne
HK1200726A1 (zh) 抗糖尿病化合物
AU341094S (en) Capsule for infusion
ZA201400901B (en) Supramolecular capsules
EP2746362A4 (en) SCINTILLATOR
EP2864361A4 (en) DOSAGE REGIME OF FUSION COMPOUNDS
HK1201534A1 (en) Pharmaceutical compounds
GB201119799D0 (en) Pharmaceutical compounds
GB2525835B (en) Pharmaceutical agent
PL2768485T3 (pl) Nanozawiesina farmaceutyczna
EP2731610A4 (en) PHARMACEUTICAL COMBINATION
GB201118876D0 (en) Pharmaceutical compounds
GB201113163D0 (en) Pharmaceutical compounds
EP2687212A4 (en) DRUG AGENT
RS60294B1 (sr) Nesvarljive kapsule za isporuku materijala koji apsorbuju tečnosti
ZA201400726B (en) Anticancer agent
IL229060A (en) Pharmaceuticals containing paclitaxel orotate
GB201118839D0 (en) Passive fluid detector
GB201118874D0 (en) Pharmaceutical compounds
GB201118875D0 (en) Pharmaceutical compounds
GB201117359D0 (en) Pharmaceutical compounds
GB201105026D0 (en) Pharmaceutical compounds
GB201108234D0 (en) Pharmaceutical agent
GB201112893D0 (en) Supramolecular Capsules